Zobrazeno 1 - 10
of 70
pro vyhledávání: '"GROWTH HORMONE/therapeutic use"'
Autor:
Madalena Meira Nisa, Miguel Vieira Martins, Bárbara Barroso de Matos, Joana Simões Monteiro, Catarina Marques Duarte, Brígida Robalo, Carla Pereira, Lurdes Sampaio
Publikováno v:
Acta Médica Portuguesa, Vol 35, Iss 13 (2022)
Introduction: Prader-Willi syndrome is a multisystemic genetic disorder associated with shorter adult height. Nowadays, all paediatric Prader-Willi syndrome patients are considered for growth hormone treatment. We present the experience of this treat
Externí odkaz:
https://doaj.org/article/af7c80aa08d44c2ba4e26e0f047120df
Publikováno v:
Journal of Education, Health and Sport, Vol 10, Iss 8, Pp 157-168 (2020)
Introduction and objective: Prader-Willi syndrome (PWS) is a severe genetic disorder being manifested by several symptoms such as infantile hypotonia and poor thriving outcomes, low height, hyperphagia, endocrine, reproductive and internal malfunctio
Externí odkaz:
https://doaj.org/article/6a0f35cc04204c9294092d3b54e2ab8b
Publikováno v:
Acta Clinica Croatica, Vol 57., Iss 4., Pp 744-754 (2018)
Prader-Willi syndrome (PWS) is the most common cause of morbid obesity in childhood. It is the consequence of the lack of expression of genes on the paternally inherited 15q11.2-q13 region. Hyperphagia, obesity, short stature, psychomotor retardation
Externí odkaz:
https://doaj.org/article/57493f22181a46e0b010320401faac9b
Autor:
Mai C Arlien-Søborg, Michael Alle Madsen, Jakob Dal, Thomas Krusenstjerna-Hafstrøm, Steffen Ringgaard, Nickolaj Skou, Morten Høgild, Jens Otto Lunde Jørgensen
Publikováno v:
Arlien-Søborg, M C, Madsen, M A, Dal, J, Krusenstjerna-Hafstrøm, T, Ringgaard, S, Skou, N, Høgild, M & Jørgensen, J O L 2023, ' Ectopic lipid deposition and insulin resistance in patients with GH disorders before and after treatment ', European Journal of Endocrinology, vol. 188, no. 1, lvac014 . https://doi.org/10.1093/ejendo/lvac014
Arlien-Søborg, M C, Madsen, M A, Dal, J, Krusenstjerna-Hafstrøm, T, Ringgaard, S, Skou, N, Høgild, M & Jørgensen, J O L 2023, ' Ectopic lipid deposition and insulin resistance in patients with GH disorders before and after treatment ', European Journal of Endocrinology, vol. 188, no. 1 . https://doi.org/10.1093/ejendo/lvac014
Arlien-Søborg, M C, Madsen, M A, Dal, J, Krusenstjerna-Hafstrøm, T, Ringgaard, S, Skou, N, Høgild, M & Jørgensen, J O L 2023, ' Ectopic lipid deposition and insulin resistance in patients with GH disorders before and after treatment ', European Journal of Endocrinology, vol. 188, no. 1 . https://doi.org/10.1093/ejendo/lvac014
Objectives Insulin resistance is associated with ectopic lipid deposition. Growth hormone (GH) status also modulates ectopic lipid accumulation, but how this associates with insulin resistance in patients with GH disorders is not well established. De
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84bb0f3394143050b7dc492a89e23446
https://doi.org/10.1093/ejendo/lvac014
https://doi.org/10.1093/ejendo/lvac014
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Peter E. Clayton, Andrew Whatmore
Publikováno v:
Clayton, P & Whatmore, A 2019, ' Two years in growth hormone 2017–18 ', Growth Hormone & IGF Research, vol. 48-49, pp. 60-64 . https://doi.org/10.1016/j.ghir.2019.10.003
This brief review highlights new studies in three areas of the GH field, namely diagnostics, therapeutics and biomarkers.The diagnosis of GH deficiency has always presented a challenge: there is no “gold standard” test of GH status, and GH levels
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fcd20df13885994a1403b90a737a823
https://doi.org/10.1016/j.ghir.2019.10.003
https://doi.org/10.1016/j.ghir.2019.10.003
Autor:
Niels Møller, René Frydensbjerg Andersen, Søren Rittig, Esben Thyssen Vestergaard, Jens Otto Lunde Jørgensen
Publikováno v:
Vestergaard, E T, Moller, N, Andersen, R F, Rittig, S & Jorgensen, J O L 2019, ' Acute Intravenous Acyl Ghrelin Infusion Induces Thirst but Does Not Affect Sodium Excretion-Two Randomized, Double Blind, Placebo Controlled Crossover Studies in Hypopituitary Patients ', European Journal of Endocrinology, vol. 181, no. 1, pp. 23-30 . https://doi.org/10.1530/EJE-19-0027
Objective Acyl ghrelin, which is the endogenous ligand for the growth hormone secretagogue receptor, potently stimulates pituitary growth hormone release, and to some degree adrenocorticotropic hormone and prolactin. Ghrelin is also orexigenic and ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0275d9614eb1d0f9446c613eff52883f
https://doi.org/10.1530/eje-19-0027
https://doi.org/10.1530/eje-19-0027
Autor:
Loureiro, Tomás, Rodrigues Barros, Sandra, Carreira, Ana Rita, Moraes, Filipe, Carreira, Pedro, Vide Escada, Ana, Campos, Nuno
Publikováno v:
Revista Sociedade Portuguesa de Oftalmologia; Vol. 45 No. 2 (2021); 109-112
Revista Sociedade Portuguesa de Oftalmologia; Vol. 45 N.º 2 (2021); 109-112
Revista Sociedade Portuguesa de Oftalmologia; Vol. 45 N.º 2 (2021); 109-112
Apresentamos um caso clínico de hipertensão intracraniana (HIC) numa criança com síndrome de Turner sob tratamento com hormona do crescimento (HC). Criança de 14 anos com síndrome de Turner sob terapêutica hormonal com estrogénio e ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a6113495fd4c5004f9025aad9508a2a
https://revistas.rcaap.pt/oftalmologia/article/view/23911
https://revistas.rcaap.pt/oftalmologia/article/view/23911